Brendan P. Eckelman - 24 May 2024 Form 3 Insider Report for Inhibrx Biosciences, Inc. (INXB)

Signature
/s/ Kelly D. Deck, Chief Financial Officer of Inhibrx Biosciences, Inc., as attorney-in-fact
Issuer symbol
INXB
Transactions as of
24 May 2024
Transactions value $
$0
Form type
3
Date filed
24 May 2024, 16:46
Previous filing
24 May 2024
Next filing
30 May 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney